News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC
the-express.com
Jan 26, 2025, 17:30

Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X:

“Pan-RAS inhibitor Daraxonrasib in 2L of pancreatic cancer

ORR KRAS G12X: 36%, RAS mt: 27%

For comparison ORR with nal-IRI-FU/LV in NAPOLI-1: 7.7%.”

Pan-RAS Inhibitor Shows Early, Deep Molecular Responses in PDAC

Additional information.

ASCOGI25 cancer Erman Akkus OncoDaily Oncology
Special Coverage
Drugs
Feb 25, 2025, 16:56
Tarlatamab (Imdelltra): What Patients Need to Know About
Science
Feb 25, 2025, 15:10
Wafaa M Rashed: Genomic Innovation for Economic Development
Drugs
Feb 25, 2025, 14:43
Tarlatamab (Imdelltra): Uses in Cancer, Side Effects, Dosages, Expectations, and More
Blog
Feb 25, 2025, 14:12
5 articles suggested by Wafik El-Deiry
Blog
Feb 25, 2025, 14:04
M. Bilal Abid: Concluded the PANAO 2025 conference
Blog
Feb 25, 2025, 13:56
Jasmin Hundal: What Drives Cancer Risk in Adults vs. Children?
Blog
Feb 25, 2025, 13:46
Enrico Pozzo: I will join Humanitas Research Hospital in Milan as staff member
Career
Feb 25, 2025, 13:39
Patrizia Cavazzoni Rejoins Pfizer as Chief Medical Officer and Executive Vice President
Blog
Feb 25, 2025, 13:38
Sean Burroughs: 2025 Funding Rounds and Growing Therapeutic Trends
Blog
Feb 25, 2025, 13:28
Exploratory analysis of biomarkers and histology in DUO-E pMMR - Spanish Gynaecological Cancer Research Group
Science
Feb 25, 2025, 13:26
Partha Basu: 'Screen, triage and treat' vs 'screen and treat' for WLHIV positive on HPV test
Blog
Feb 25, 2025, 11:39
Applonia Rose: Exciting findings on prognostic scoring in metastatic renal cell carcinoma